A Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With Gemcitabine and Abraxane® in Patients With Advanced Pancreatic Cancer
Clinical trial NCT02045589 · COMPLETED
Trial details
- NCT number
- NCT02045589
- Sponsor
- Theriva Biologics SL
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2016-10-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.